CR Bard CE-marks Memotherm carotid stent:
This article was originally published in Clinica
Executive Summary
CR Bard has CE-marked its nitinol Memotherm carotid stent. The device is designed to self expand once it is inserted and conform to the artery. The company believes this will help to contain the build-up of artheroscleroic plaque which can lead to a stroke. The stent's thermoelastic properties also prevent deformation which might be caused by external compression in the neck. Carotid artery disease is one of the major precursors to ischemic stroke in the US. According to Murray Hill, New Jersey-based Bard, carotid artery stenting provides a less invasive and less expensive way of treating this disease.